Cargando…

Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia

BACKGROUND: The present study investigated factors associated with therapeutic benefits after autologous bone marrow cell (BMC) therapy in patients with “no-option” critical limb ischemia (CLI). METHODS AND RESULTS: Sixty-two patients with advanced CLI (Rutherford category 5 or 6) not eligible for r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madaric, Juraj, Klepanec, Andrej, Valachovicova, Martina, Mistrik, Martin, Bucova, Maria, Olejarova, Ingrid, Necpal, Roman, Madaricova, Terezia, Paulis, Ludovit, Vulev, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987968/ https://www.ncbi.nlm.nih.gov/pubmed/27530339 http://dx.doi.org/10.1186/s13287-016-0379-z

Ejemplares similares

Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia
por: Madaric, Juraj, et al.
Publicado: (2017)

Characterization of Mesenchymal Stem Cells of “No-Options” Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells
por: Altaner, Cestmir, et al.
Publicado: (2013)

Current Status of Cell-Based Therapy in Patients with Critical Limb Ischemia
por: Jaluvka, Frantisek, et al.
Publicado: (2020)

Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-derived Mononuclear Cell Implantation in Patients with No-option Critical Limb Ischemia
por: Yanishi, Kenji, et al.
Publicado: (2020)

Autologous Peripheral Blood Mononuclear Cells for Limb Salvage in Diabetic Foot Patients with No-Option Critical Limb Ischemia
por: Scatena, Alessia, et al.
Publicado: (2021)

Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia
por: Pan, Tianyue, et al.
Publicado: (2019)

Autologous Stem Cells Transplantation for No-Option Angiitis-Induced Critical Limb Ischemia: Recurrence and New Lesion
por: Liu, Hao, et al.
Publicado: (2022)

Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia
por: Skóra, Jan, et al.
Publicado: (2014)

Percutaneous autologous bone marrow transplantation for the treatment of delayed union of limb bone in children
por: Wu, Jun, et al.
Publicado: (2018)

Relationship between cell number and clinical outcomes of autologous bone-marrow mononuclear cell implantation in critical limb ischemia
por: Yusoff, Farina Mohamad, et al.
Publicado: (2020)

Early Results of Clinical Application of Autologous Whole Bone Marrow Stem Cell Transplantation for Critical Limb Ischemia with Buerger’s Disease
por: Heo, Seon-Hee, et al.
Publicado: (2016)

Review of the Long-term Effects of Autologous Bone-Marrow Mononuclear Cell Implantation on Clinical Outcomes in Patients with Critical Limb Ischemia
por: Yusoff, Farina Mohamad, et al.
Publicado: (2019)

Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience
por: Fang, Gang, et al.
Publicado: (2020)

Effect of Atorvastatin on Angiogenesis-Related Genes VEGF-A, HGF and IGF-1 and the Modulation of PI3K/AKT/mTOR Transcripts in Bone-Marrow-Derived Mesenchymal Stem Cells
por: Adamičková, Adriana, et al.
Publicado: (2023)

Combined Use of Autologous Bone Marrow-derived Stem Cells and Platelet-rich Plasma for Ovarian Rejuvenation in Poor Responders
por: Tandulwadkar, Sunita, et al.
Publicado: (2020)

Peripheral and Central Effects of Melatonin on Blood Pressure Regulation
por: Pechanova, Olga, et al.
Publicado: (2014)

New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon?
por: Paulis, Ludovit, et al.
Publicado: (2015)

Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology
por: Hrenak, Jaroslav, et al.
Publicado: (2016)

Radiation dose and image quality of CT coronary angiography in patients with high heart rate or irregular heart rhythm using a 16-cm wide detector CT scanner
por: Ondrejkovic, Marian, et al.
Publicado: (2022)

Autologous Bone-Marrow Mesenchymal Stem Cell Implantation and Endothelial Function in a Rabbit Ischemic Limb Model
por: Mikami, Shinsuke, et al.
Publicado: (2013)

Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results
por: Guo, Jianming, et al.
Publicado: (2018)

Stakeholder Values and Preferences in Lower Limb Amputation for No-Option Chronic Limb Threatening Ischemia
por: Nieuwstraten, Jelle A, et al.
Publicado: (2021)

Therapeutic perspectives in hypertension: novel means for renin–angiotensin–aldosterone system modulation and emerging device-based approaches
por: Unger, Thomas, et al.
Publicado: (2011)

Melatonin as a rational alternative in the conservative treatment of resistant hypertension
por: Simko, Fedor, et al.
Publicado: (2019)

Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers
por: Panunzi, Andrea, et al.
Publicado: (2022)

Renin–Angiotensin–Aldosterone System: Friend or Foe—The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions
por: Simko, Fedor, et al.
Publicado: (2021)

Response of Escherichia coli minimal ter operon to UVC and auto-aggregation: pilot study
por: Jánošíková, Lenka, et al.
Publicado: (2021)

Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients
por: Arici, Vittorio, et al.
Publicado: (2015)

Limb salvage in diabetic patients with no-option critical limb ischemia: outcomes of a specialized center experience
por: Dalla Paola, Luca, et al.
Publicado: (2019)

Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles
por: Hulme, Charlotte H., et al.
Publicado: (2017)

Bone marrow stem cell injection for the treatment of critical limb ischemia
por: Shindo, S
Publicado: (2007)

Characteristics and Outcome for Persons with Diabetic Foot Ulcer and No-Option Critical Limb Ischemia
por: Meloni, Marco, et al.
Publicado: (2020)

Cellular therapies in no-option critical limb ischemia: present status and future directions
por: Kwiatkowski, Tomasz, et al.
Publicado: (2022)

RISK EVALUATION IN THE LOW-DOSE RANGE CT FOR RADIATION-EXPOSED CHILDREN, BASED ON DNA DAMAGE
por: Jánošíková, Lenka, et al.
Publicado: (2019)

Aspiration Thrombectomy in Patients with Large Vessel Occlusion and Mild Stroke: A Single-Center Experience
por: Haring, Jozef, et al.
Publicado: (2021)

Autologous Pancreatic Islet Transplantation in Human Bone Marrow
por: Maffi, Paola, et al.
Publicado: (2013)

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma
por: Paquin, Ashley, et al.
Publicado: (2020)

Percutaneous Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Implantation Is Safe for Reconstruction of Human Lower Limb Long Bone Atrophic Nonunion
por: Emadedin, Mohsen, et al.
Publicado: (2017)

Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension
por: Stanko, Peter, et al.
Publicado: (2020)

Ghrelin, MicroRNAs, and Critical Limb Ischemia: Hungering for a Novel Treatment Option
por: Neale, Joshua P. H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uon5khgrrdvbjrk9luan69r6s1